CHD4 regulates the DNA damage response and RAD51 expression in glioblastoma

Glioblastoma (GBM) is a lethal brain tumour. Despite therapy with surgery, radiation, and alkylating chemotherapy, most people have recurrence within 6 months and die within 2 years. A major reason for recurrence is resistance to DNA damage. Here, we demonstrate that CHD4, an ATPase and member of th...

Descripción completa

Detalles Bibliográficos
Autores principales: McKenzie, Lisa D., LeClair, John W., Miller, Kayla N., Strong, Averey D., Chan, Hilda L., Oates, Edward L., Ligon, Keith L., Brennan, Cameron W., Chheda, Milan G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6418088/
https://www.ncbi.nlm.nih.gov/pubmed/30872624
http://dx.doi.org/10.1038/s41598-019-40327-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6418088/
https://www.ncbi.nlm.nih.gov/pubmed/30872624
http://dx.doi.org/10.1038/s41598-019-40327-w

Ejemplares similares